Sorrento Therapeutics, Inc. (SRNE): Price and Financial Metrics


Sorrento Therapeutics, Inc. (SRNE)

Today's Latest Price: $1.54 USD

0.03 (1.99%)

Updated Oct 23 8:00pm

Add SRNE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 328 in Biotech

See all "A" rated Strong Buy stocks

SRNE Stock Summary

  • With a year-over-year growth in debt of 1,651.67%, Sorrento Therapeutics Inc's debt growth rate surpasses 98.14% of about US stocks.
  • Over the past twelve months, SRNE has reported earnings growth of 2,126.07%, putting it ahead of 99.16% of US stocks in our set.
  • As for revenue growth, note that SRNE's revenue has grown -84.49% over the past 12 months; that beats the revenue growth of just 1.36% of US companies in our set.
  • Stocks that are quantitatively similar to SRNE, based on their financial statements, market capitalization, and price volatility, are EGAN, MCHX, AUDC, SMSI, and TER.
  • SRNE's SEC filings can be seen here.. And to visit Sorrento Therapeutics Inc's official web site, go to www.sorrentotherapeutics.com.
SRNE Daily Price Range
SRNE 52-Week Price Range

SRNE Stock Price Chart More Charts


SRNE Price/Volume Stats

Current price $1.54
Prev. close $1.51
Day low $1.50
Day high $1.59
50-day MA $2.05
200-day MA $2.76
52-week high $6.50
52-week low $1.39
Volume 566,100
Avg. volume 1,741,708
Dividend yield N/A
Market Cap 205.61M

Sorrento Therapeutics, Inc. (SRNE) Company Bio


Sorrento Therapeutics is a clinical stage oncology company developing new treatments for cancer and associated pain. The company was founded in 2006 and is based in San Diego, California.





SRNE Latest News Stream


Event/Time News Detail
Loading, please wait...

SRNE Latest Social Stream


Loading social stream, please wait...

View Full SRNE Social Stream

SRNE Price Returns

1-mo -30.94%
3-mo -38.40%
6-mo -59.15%
1-year -53.33%
3-year -77.78%
5-year -61.98%
YTD -35.83%
2018 -36.84%
2017 -22.45%
2016 -43.74%
2015 -13.51%
2014 24.32%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5305 seconds.